Back to User profile » Dr Pedro Santos-Moreno
Papers published by Dr Pedro Santos-Moreno:
Usefulness of Lung Ultrasound as a Method for Early Diagnosis of Interstitial Lung Disease in Patients with Rheumatoid Arthritis
Santos-Moreno P, Linares-Contreras MF, Rodríguez-Vargas GS, Rodríguez-Linares P, Mata-Hurtado A, Ibatá L, Martínez S, Rojas-Villarraga A, Diaz M, Vicente-Rabaneda EF, Quintero M, Möller I
Open Access Rheumatology: Research and Reviews 2024, 16:9-20
Published Date: 17 January 2024
Expectations and Experiences of a Group of Patients Enrolled in an Educational Program for Rheumatoid Arthritis at a Specialized Care Center in Colombia
Castiblanco-Montañez RA, Buitrago-Garcia D, Arévalo Velandia A, Garzón-Cepeda JD, Rodríguez-Florido F, Sánchez Vanegas G, Santos-Moreno P
Journal of Multidisciplinary Healthcare 2023, 16:483-492
Published Date: 22 February 2023
Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model
Santos-Moreno P, Sánchez-Vanegas G, Monterrosa-Blanco A, Rodríguez-Vargas GS, Rivero M, Rodriguez P, Calixto OJ, Rojas-Villarraga A, Castro CA
Biologics: Targets and Therapy 2022, 16:199-209
Published Date: 21 November 2022
Better Clinical Results in Rheumatoid Arthritis Patients Treated Under a Multidisciplinary Care Model When Compared with a National Rheumatoid Arthritis Registry
Santos-Moreno P, Rodríguez-Vargas GS, Martínez S, Ibatá L, Villarreal-Peralta L, Aza-Cañon A, Rivero M, Rodriguez P, Rojas-Villarraga A
Open Access Rheumatology: Research and Reviews 2022, 14:269-280
Published Date: 18 November 2022
Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
Santos-Moreno P, Rodríguez-Vargas GS, Martínez S, Ibatá L, Rojas-Villarraga A
Open Access Rheumatology: Research and Reviews 2022, 14:255-267
Published Date: 4 November 2022
Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
Santos-Moreno P, Martinez S, Ibata L, Villarreal L, Rodríguez-Florido F, Rivero M, Rojas-Villarraga A, Galarza-Maldonado C
Biologics: Targets and Therapy 2022, 16:107-117
Published Date: 13 July 2022
Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients
Santos-Moreno P, Martinez S, Ibatá L, Villarreal L, Rivero M, Rojas-Villarraga A
Biologics: Targets and Therapy 2021, 15:433-440
Published Date: 22 October 2021
Centers of Excellence Implementation for Treating Rheumatoid Arthritis in Colombia: A Cost-Analysis
Santos-Moreno P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, de la Hoz-Restrepo F, Alvis-Guzmán N
ClinicoEconomics and Outcomes Research 2021, 13:583-591
Published Date: 23 June 2021
Quantifying Potential Cost-Savings Through an Alternative Imaging-Based Diagnostic Process in Presumptive Seronegative Rheumatoid Arthritis
Santos-Moreno P, Alvis-Zakzuk NJ, Castillo E, Villarreal L, Pineda C, Sandoval H, Valencia O
ClinicoEconomics and Outcomes Research 2021, 13:519-529
Published Date: 16 June 2021
Frequency of Health Care Resource Utilization and Direct Medical Costs Associated with Psoriatic Arthritis in a Rheumatic Care Center in Colombia
Santos-Moreno P, Gómez-De la Rosa F, Parra-Padilla D, Alvis-Zakzuk NJ, Alvis-Zakzuk NR, Carrasquilla-Sotomayor M, Valencia O, Alvis-Guzmán N
Psoriasis: Targets and Therapy 2021, 11:31-39
Published Date: 18 March 2021
Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
Santos-Moreno P, Castillo P, Villareal L, Pineda C, Sandoval H, Valencia O
Open Access Rheumatology: Research and Reviews 2020, 12:249-256
Published Date: 6 November 2020